CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

Similar documents
HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

Nestlé India Outlook Hazy; Valuations Prohibitive

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

KNR Constructions Robust Performance on Execution Ramp-up

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Amber Enterprises India Ltd

India Cements Rating: Target price:

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

KEC International. Recovering from a weak phase. Institutional Equity Research. Order inflow traction remains intact

Institutional Equities

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Tata Steel BUY. Performance Highlights. 3QFY2010 Result Update I Steel

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Dalmia Bharat Enterprises

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

EBITDA 5,076 3, , EBITDA

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Cummins India Ltd Bloomberg Code: KKC IN

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Hindustan Unilever (RHS)

Strides Arcolab. Inline 4Q, recent acquisitions to deepen asset growth. Institutional Equity Research. Strides Arcolab. Pharmaceuticals India

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Balkrishna Industries

Colgate-Palmolive (India)

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Coal India. Source: Company Data; PL Research

Visaka Industries Ltd

Gillette India. Institutional Equities. 1QFY18 Result Update

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Ahluwalia Contracts (India)

Fineotex Chemical Ltd

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

The India Cements Ltd (ICEM IN) Volumes consistency maintained, confident of regaining pricing power

Hindustan Media Ventures

Sonata Software BUY. Laying the Platform for Growth. Institutional Equity Research. December 01, Target Price Rs185.

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Transport Corporation of India Ltd.

Jamna Auto Industries

Quarterly results (YE Mar) 4QFY13 4QFY14 YoY(%) FY13 FY14 YoY(%)

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Astra Microwave Products

Near-term pressure, but long-term outlook positive

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Transport Corporation of India Ltd.

Mahindra & Mahindra Ltd.

Simplex Infrastructures

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Key estimate revision. Financial summary. Year

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

Transcription:

4QFY18 Result Update May 28, 2018 Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1 Subdued Operating Show on Cost Pressure (ICL) has reported a subdued set of numbers for 4QFY18. Its reported EBITDA declined by ~17% YoY and ~5% QoQ to Rs1.6bn (vs. our estimate of Rs1.7bn) owing to higher-thanestimated rise (+5.5% QoQ) in cement operating cost/tonne to Rs3,920 led by higher employee cost, Freight and Power & Fuel cost. Cement EBITDA/tonne came in at Rs499 as against Rs712 and Rs628 in 4QFY17 and 3QFY18, respectively. However, net profit stood at Rs353mn (vs. our estimate of Rs200mn) led by lower tax and interest cost. Whilst receivables declined to Rs6.3bn (vs. Rs7.9bn in 1HFY18), which aided ICL to sequentially reduce its gross debt by Rs2.3bn, on YoY basis its debt rose by Rs2bn to Rs31.3bn again reaching the peak witnessed in FY15. We believe that ICL s inability to pare down debt amid no capacity expansion may not warrant any rerating of the stock, while the likely pick-up in pricing scenario and acceleration in demand in TN are likely to aid ICL s profitability. Though we cut our EBITDA estimate by 11% and 8% for FY19E and FY20E, respectively mainly to factor in cost inflation, the current valuations appear to be attractive following a sharp correction in stock price over last three months. We maintain our recommendation on the stock with a downwardly revised Target Price of Rs180. Share price (%) 1 mth 3 mth 12 mth Absolute performance (7.1) (15.6) (32.4) Relative to Nifty (7.4) (15.8) (43.9) Shareholding Pattern (%) Mar'18 Dec'17 Promoter 28.4 28.4 Public 71.6 71.6 1 Year Stock Price Performance 240 220 200 Moderate YoY Growth in Revenue; Sales Volume up 6.4% YoY Revenue grew by a moderate 4% YoY to Rs14bn mainly led by 6.4% YoY growth in sales volume growth to 3.09mnT. A substantial demand improvement in AP/Telangana along with gradual demand revival in Tamil Nadu aided sales volume growth. Southern demand grew by 15% in 4QFY18, which ICL expects to sustain in 1HFY19 as well. Further, revenue from Shipping, Trishul (RMC) and Wind Mill stood at Rs43mn, Rs245mn and Rs43mn, respectively. Cost Inflation Mars Operating Performance Despite 1.7% QoQ rise in realisation, ICL s EBITDA declined by 17% YoY and 5% QoQ to Rs1.6bn led by higher-than-estimated surge in operational cost. While Freight cost/tonne increased by 4% QoQ to Rs1,074, Power & Fuel cost/tonne rose by 1% QoQ to Rs1,131. Notably, employees cost too surged by 30% QoQ to Rs996mn mainly due to non-recurring items of ~Rs170mn during the quarter. Cement EBITDA/tonne stood at Rs499 vs. Rs712 and Rs628 in 4QFY17 and 3QFY18, respectively. Looking ahead, we believe that likely improvement in realisation may aid ICL s operational performance. 180 160 140 120 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Note: CMp as on May 28, 2018 Mar-18 Mar-18 Apr-18 May-18 Outlook & Valuation Higher debt, absence of pricing recovery, cost pressure along with ambiguity over capacity expansion have been major headwinds for the stock performance for last couple of months. We believe that demand revival in Southern market (including Tamil Nadu) along with likely up-tick in realisation is expected to augur well for the stock, which following a sharp correction over last three months is available at a attractive price point (6.3x FY20 EBITDA). We maintain our recommendation on the stock with a downwardly revised Target Price of Rs180. Key Financials (Rs mn) FY17 FY18E FY19E FY20E Sales 50,792 53,407 59,502 65,019 EBITDA 8,610 6,928 8,809 10,646 APAT 1734 1006 2292 3606 EPS (Rs) 5.6 3.3 7.4 11.7 DPS (Rs) 1.2 1.0 1.2 2.4 P/E (x) 23.6 40.7 17.9 11.4 P/B (x) 0.8 0.8 0.8 0.7 EV/EBITDA (x) 8.1 10.4 8.1 6.4 RoE (%) 3.4 2.0 4.3 6.5 Divi. Yield (%) 0.9 0.7 0.9 1.8 Source: Company, RSec Research Research Analyst: Binod Modi Contact: 022 3320 1097 Email: binod.modi@relianceada.com 1

Risks to the View Government s failure to revive activities in infrastructure space. Any significant deterioration in pricing environment and substantial rise in input cost. Conference Call Key Takeaways Demand in Southern Markets: Demand in Southern markets grew by 15% YoY and 6% YoY in 4QFY18 and FY18, respectively. In 4QFY18, while demand in AP+Telangana grew by 37% YoY (2.2mnT/month consumption), the demand in Karnataka increased by 10% YoY (1.7mnT/month). Notably, demand in Tamil Nadu+Kerala grew by 4% YoY in 4QFY18 (2.1mnT/month) vs. 10% YoY decline in 9MFY18. While the demand in Southern + Western markets in expected to grow by 10% in FY19E, the Management expects 15% demand growth to sustain in 1HFY19. Demand Drivers: Infrastructure continued to drive demand in Southern region, which also restricted blended cement demand and put pressure on cost too. With the improved sand availability in Tamil Nadu markets, demand witnessed a visible up-tick. The Management expects the demand momentum in Tamil Nadu to accelerate further once the sand prices come down in ensuing months. Pricing Outlook: While ICL remains hopeful for price recovery, it does not seem to be sure of any meaningful price improvement in the near-term despite higher demand. Clinker Production & Utilisation: Clinker production stood at 8.0mnT (76% utilisation) in FY18, while cement utilisation stood at 79% and 74% in 4QFY18 and FY18, respectively. Capacity Expansion & Capex: Though the Management did not explicitly share its capacity expansion plan, it maintained that ICL has all requisite clearances for Brownfield expansion at its three plants. Stating that ICL has suicient limestone reserve (up to 2bn tonne) to support expansion, the Management stated that clarity over expansion may emerge in next two quarters. Further, ICL is yet to formalise any plan for setting up WHRS at Chilamakur plant. It is likely to incur a regular capex of Rs2.5bn in FY19E. Other Expenditures: The Management attributed higher other expenditure in 4QFY18 to: (a) higher packaging charges (which is likely to increase further by 3-4% in 1QFY19); (b) higher maintenance cost (Rs390mn); and (c) higher other overheads (Rs350mn). Lead Distance: Though the lead distance remained flat during the quarter, the management expects it to come down in coming months with the visible demand revival in Tamil Nadu. Working Capital Cycle & Debt: With Rs1.7bn reduction in receivable to Rs6.3bn in 4QFY18 (vs. 1HFY18), ICL s gross reduced to Rs31.3bn vs. Rs33.6bn in 3QFY18 and Rs29.2bn in FY17. However, ICL expects the debt to shoot up further in 1QFY19 led by incentives and other schemes given in the beginning of year. Debt repayment liability for FY19 stood at Rs1.55bn. f f Tax Incentives under 80 IA: ICL availed tax exemption up to Rs360mn in FY18 for its captive power plants, which it expects to avail for next 9 years. 2

Exhibit 1: Quarterly Performance India Cement (Rs mn) 4QFY18 4QFY17 % yoy 3QFY18 % qoq Net Sales 13,978 13,436 4.0 12,131 15.2 (Increase) / Decrease in Stock in Trade and WIP (37) (154) 99 Consumption of raw materials, components, etc. 2535 2294 10.5 2227 13.8 Stock in Trade (28) 0 60 Total Raw material consumed 2,470 2,140 15.4 2,385 3.5 % Net Sales 17.7 15.9 19.7 Employee Cost 996 993 0.3 764 30.4 % Net Sales 7.1 7.4 6.3 Power & Fuel Cost 3,492 3,227 8.2 3,065 14.0 % Net Sales 25.0 24.0 25.3 Transportation & Handling Charges 3,315 3,110 6.6 2,811 17.9 % Net Sales 23.7 23.1 23.2 Other Expenditures 2,119 2,066 2.6 1,433 47.9 % Net Sales 15.2 15.4 11.8 Total Expenditures 12,393 11,536 7.4 10,458 18.5 % Net Sales 88.7 85.9 86.2 Cement Cost/tonne (Rs) 3,920 3,866 1.4 3,715 5.5 EBITDA 1,585 1,900 (16.5) 1,673 (5.2) EBITDA margin (%) 11.3 14.1 13.8 Cement EBITDA 1,541 2,065 (25.4) 1,711 (9.9) EBITDA per tonne 499 712 (29.9) 628 (20.5) Depreciation 664 639 3.9 633 4.8 EBIT 921 1,260 (26.9) 1,039 (11.4) Interest and Finance Charges 718 820 (12.4) 924 (22.2) Other Income 39 17 129.2 37 6.8 PBT 242 458 (47.0) 152 59.1 Tax Expenses (110.3) 115 (196.2) - - % Tax PAT 353 343 2.9 152 131.4 Source: Company, RSec Research 3

Exhibit 2: Revised vs. Old Estimates FY19E FY20E Old Revised % change Old Revised % change Volume (mnt) 12.60 12.66 0.5 13.37 13.37 - Realization (Rs/tonne) 4,788 4,657 (2.7) 4,624 4,820 4.2 Sales (Rs mn) 60,837 59,502 (2.2) 66,486 65,019 (2.2) EBITDA (Rs mn) 9,915 8,809 (11.2) 11,563 10,646 (7.9) EBITDA margins (%) 16.3 14.8 17.4 16.4 PAT (Rs mn) 3,098 2,292 (26.0) 4,040 3,606 (10.7) PAT margins (%) 5.1 3.9 6.1 5.5 EPS (Rs) 10.05 7.44 (26.0) 13.10 11.70 (10.7) Source: RSec Research 4

Profit & Loss Y/E Mar (Rs mn) FY17 FY18 FY19E FY20E Net sales 50,792 53,407 59,502 65,019 % yoy growth 20.1 5.1 11.4 9.3 Total Cost 42,181 46,479 50,693 54,373 Ram Material Expenditures 10,617 10,779 12,347 13,561 Employee Costs 3,603 3,971 3,404 3,736 Power and Fuel 10,597 12,389 14,184 14,978 Freight and Forewarding 15,663 18,155 19,457 20,756 Other Expenditures 1,701 1,185 1,300 1,342 EBITDA 8,610 6,928 8,809 10,646 EBITDA Margin (%) 17.0 13.0 14.8 16.4 Depreciation 2,571 2,559 2,615 2,692 Interest 3,605 3,402 3,543 3,381 Other Income 165 194 214 235 PBT 2,600 1,161 2,865 4,808 Tax 867 155 573 1,202 Eective tax rate (%) 33.3 13.3 20.0 25.0 Net Profit 1,734 1,006 2,292 3,606 YoY Growth (%) 33.4 (41.9) 127.7 57.4 APAT 1,734 1,006 2,292 3,606 PAT % 3.4 1.9 3.9 5.5 5

Balance Sheet Y/E Mar (Rs mn) FY17 FY18E FY19E FY20E Share Capital 3,081 3,081 3,081 3,081 Reserves & Surplus 48,017 48,728 50,650 53,516 Total Shareholder's funds 51,099 51,809 53,731 56,598 Secured Loans 23,983 28,180 27,180 25,180 Unsecured Loans 5,230 3,098 3,498 2,698 Total Debt 29,213 31,278 30,678 27,878 Deered Tax liability 6,556 6,532 6,556 6,556 Other NC Liabilities 1,887 1,711 1,866 2,001 TOTAL LIABILITIES 88,756 91,331 92,832 93,034 APPLICATION OF FUNDS Gross Block 75,015 75,809 78,309 80,309 Less: Accumulated Depreciation 5,286 7,846 10,461 13,152 Net Block 69,729 67,963 67,848 67,156 CWIP 1,278 1,712 1,712 1,712 Investments 6,190 5,884 5,884 5,884 Other NC Assets 12,295 14,124 14,998 16,032 Inventories 7,450 6,723 7,336 8,016 Sundry Debtors 5,089 6,295 7,336 8,016 Cash & Bank 68 84 189 298 Loans & Advances 4,354 4,474 4,891 4,988 Current Liablities & Prov. 17,697 15,927 17,361 19,068 Net Current Assets (737) 1,648 2,391 2,250 TOTAL ASSETS 88,756 91,331 92,832 93,034 6

Cash Flow Statement Y/E Mar (Rs mn) FY17 FY18E FY19E FY20E PBT before Extraordinary Items 2,600 1,161 2,865 4,808 Depreciation 2,571 2,559 2,615 2,692 Interest Exp. 4,223 3,402 3,543 3,381 Others (714) - - - Operation Profit before WC changes 8,680 7,122 9,023 10,881 Trade and Other Receivables (1,336) (3,155) (2,331) (1,812) Inventories (1,456) 727 (613) (680) Trade Payables 2,905 (1,947) 1,589 1,843 Cash generated from Operation 8,794 2,748 7,667 10,232 Direct Taxes (637) (179) (549) (1,202) Net cash from Operating Activities 8,157 2,569 7,118 9,030 Purchase of Fixed Assets (969) (1,228) (2,500) (2,000) Others (209) 307 - - Net cash from Investing activities (1,178) (921) (2,500) (2,000) Proceed from Long Term Borrowings - 2,065 (600) (2,800) Interest paid/divi.paid (net of remission) (4,555) (3,697) (3,913) (4,121) Others (2,338) - - - Net Cash from financing activities (6,894) (1,632) (4,513) (6,921) Incr./ (Decr.) in cash & cash equivalent 85 16 105 109 Opening cash 67 68 84 189 Closing Cash 68 84 189 298 7

Key Ratio Y/E Mar FY17 FY18E FY19E FY20E Valuation Ratio (x) P/E 23.6 40.7 17.9 11.4 P/CEPS 9.5 11.5 8.4 6.5 P/BV 0.8 0.8 0.8 0.7 EV/EBIDTA 8.1 10.4 8.1 6.4 EV/Sales 1.4 1.4 1.2 1.1 EV/tonne (USD) 69 71 71 68 Dividend Payout (%) 21.3 29.4 16.1 20.5 Dividend Yield (%) 0.9 0.7 0.9 1.8 Per Share Data (Rs) EPS (Basic) 5.6 3.3 7.4 11.7 EPS (Diluted) 5.6 3.3 7.4 11.7 CEPS 14.0 11.6 15.9 20.4 DPS 1.2 1.0 1.2 2.4 Book Value 166 168 174 184 EBITDA/tone 780 619 696 796 Returns (%) RoCE 7.0 5.1 7.0 8.8 RoE 3.4 2.0 4.3 6.5 Turnover ratios (x) Asset Turnover (Gross block) 0.7 0.7 0.8 0.8 Inventory (days) 54 46 45 45 Receivables (days) 37 43 45 45 Payables (days) 114 114 114 114 8

Rating Guides Rating Expected absolute returns (%) over 12 months >10% HOLD -5% to 10% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or oering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, ailiates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, ailiates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely aected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces aecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be aected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may aect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an oicer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U65990MH2005PLC154052. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 011234839, Depository Participants: CDSL IN-DP-257-2016 IN-DP-NSDL-363-2013, Research Analyst: INH000002384); AMFI ARN No.29889. 9